|
It was reported that shortly after the cardiac resynchronization therapy defibrillator (crt-d) implant, the patient experienced a large hematoma on the left side for which incision and drainage was performed on the left side.It was suspected that subsequently the patient developed infection with weakness, bacteremia, erosion and organism identified as methicillin sensitive staphylococcus aureus (mssa).The crt-d system was explanted.No further patient complications have been reported as a result of this event.
|
|
Continuation of d10: 407658 lead, implanted: (b)(6) 2010.5867-3m end cap, 6725 pin plug, implanted: (b)(6) 2026.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|